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a-HaloketonesAbstract A rapid synthesis of hydrazinyl thiazoles under solvent and catalyst free condition is
reported within 30 s. A series of aryl ketones/4-benzoyl pyridine thiosemicarbazone, thiosemicarba-
zide and a-haloketones were used. This is an environmentally benign microwave assisted and efﬁ-
cient method for rapid synthesis of hydrazinyl thiazoles.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
In the recent years thiazoles and their derivatives have
attracted medicinal chemists because of their biological prop-
erties and their application found in drug development for
the treatment of allergies [1], hypertension [2], inﬂammation
[3], schizophrenia [4], antibacterial [5], HIV infections [6],
hypnotics [7], and more recently for treatment of pain [8],
as ﬁbrinogen receptor antagonist with antithrombotic activity
[9], and as new inhibitors of bacterial DNA gyrase B. [10]. In
the proposed investigation the compounds to be synthesized
contain a thiazole moiety in the total heterocyclic system.
There are many examples of biologically active thiazoleswhich showed very interesting pharmacological properties
such as anti-inﬂammatory, anti-hypertensive, antibacterial
and anti HIV infectious etc. Amino thiazoles are known to
be ligands of estrogen receptors [11], as well as novel class
of adenosine receptor antagonists [12], moreover organic
compounds containing thiazole nucleus are found to possess
high second order hyper polarizability [13–16]. In view of
the importance of thiazoles and their derivatives several
methods for the synthesis of thiazole derivatives were devel-
oped [17,18]. However in spite of their potential utility many
of these reported methods suffer from drawbacks such as
harsh reaction conditions, wastage of solvents and catalyst
which have to be recovered, treated and disposed. Microwave
assisted organic reactions using dry media have attracted
much interest because of the simplicity in operation, greater
selectivity and rapid synthesis of a variety of heterocyclic
compounds. Thus it was thought worthwhile to synthesize
the thiazole derivatives using green route that is the micro-
wave organic reaction enhancement method (MORE). In this
context the present investigation leads to the microwave
assisted one pot synthesis of not yet synthesized newer
heterocyclic moiety with thiazole nucleus.
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2.1. Instruments
The IR spectrum was recorded in an AVATAR-330 FT-IR
spectrophotometer and only noteworthy absorption levels
(reciprocal centimeters) were listed. 1H NMR spectra were
recorded at 400 and 500 MHz on a Bruker AMX 400 and
500 MHz spectrophotometer using CDCl3 or DMSO-d6 as sol-
vent and TMS as the internal standard. 13C NMR spectra were
recorded at 100 and 125 MHz on a Bruker AMX 400 and
500 MHz spectrophotometer using CDCl3 or DMSO-d6 as
the solvent. HRMS (ESI) was carried out in a Bruker Maxis
instrument in the School of Chemistry, University of Hydera-
bad. Elemental analyses (CHN) were recorded on a Thermo
Finnigan Flash EA 1112 analyzer at the School of Chemistry,
University of Hyderabad. Routine monitoring of the reactions
was performed by TLC, using silica gel plates (Merck 60 F254)
and compounds were visualized with a UV light at 254 nm.
3. Synthesis
3.1. General procedure for the synthesis of thiazoles (4a–i, 6a–j)
Equimolar amounts of aryl ketones (2.0 mmol), thiosemicar-
bazide (2.0 mmol) and substituted phenacyl bromide
(2.0 mmol) are mixed and subjected to microwave irradiation
for 30–175 s at a heating of 300 W. After the reaction is com-
pleted it is taken out, the solid product is recrystallized from
ethanol to get pure compounds (4–i, 6a–j).
3.1.1. (Z)-4-(4-methoxyphenyl)-2-(2-(1-phenylethylidene)
hydrazinyl)thiazole (4a)
White solid; mp 230–233 C; 1H NMR (400 MHz, CDCl3) 2.58
(s, 3H, CH3), 3.85 (s, 3H, OCH3), 6.88 (s, CH, thiazole), 7.45
(s, 3H), 7.69–7.71 (d, 4H), 7.80 (s, 2H); 13C NMR (100 MHz,
CDCl3) 15.24, 102.47, 126.52, 126.52, 126.94, 127.49, 128.63,
128.59, 130.33, 135.74, 136.34, 141.74, 154.21, 169.91; FT-IR
(KBr) 1509.96, 1616.91, 3121.68; HRMS (ESI-MS) Exert M.
W:323.1092; found 324.1173 (M+H+); CHN analysis: C18-
H17N3OS. Anal. Calcd. (%) for: C, 66.85; H, 5.30; N, 12.99;
found (%): C, 66.72; H, 5.36; N, 12.85.
3.1.2. (Z)-4-(4-methoxyphenyl)-2-(2-(1-(4-nitrophenyl)
ethylidene)hydrazinyl)thiazole (4b)
Orange yellow solid; mp 191–194 C; 1H NMR (400 MHz,
CDCl3) d 2.59 (s, 3H, CH3), 3.86 (s, 3H, OCH3), 6.69 (s,
CH, thiazole), 6.99, 7.02 (d, 2H), 7.67, 7.69 (d, 2H), 7.95,
7.98 (d, 2H) 8.28, 8.30 (d, 2H); 13C NMR (100 MHz, CDCl3)
d 15.74, 55.53, 99.59, 115.02, 123.91, 127.27, 127.45, 139.64,
142.18, 153.43, 161.28, 169.94; FT-IR (KBr) 1585.90,
1613.00, 3198.89; HRMS (ESI-MS) Exert M. W: 368.0943;
found: 369.1022 (M+H+); CHN analysis: C18H16N4O3S.
Anal. Calcd. (%) for: C, 58.68; H, 4.38; N, 15.21; found
(%): C, 58.45; H, 4.31; N, 15.12.
3.1.3. (Z)-4-(4-methoxyphenyl)-2-(2-(1-(4-methoxyphenyl)
ethylidene)hydrazinyl)thiazole (4c)
Dirty white solid; mp 270–273 C; 1H NMR (400 MHz,
DMSO-d6) d 2.38 (s, 3H, CH3), 3.82 (s, 6H, OCH3), 6.63 (s,CH, thiazole), 6.91–6.96 (t, 4H), 7.66, 7.68 (d, 2H), 7.73,
7.75 (d, 2H); 13C NMR (100 MHz, CDCl3) d 14.68, 55.43,
100.02, 113.95, 114.58, 123.13, 127.19, 127.60, 128.93, 129.30,
144.76, 151.90, 160.43, 161.17, 169.60; FT-IR (KBr) 1576.23
1621.31, 3143.13; HRMS (ESI-MS) Exert M. W: 353.1198;
found: 354.1277 (M+H+); CHN analysis: C19H19N3O2S.
Anal. Calcd. (%) for: C, 64.57; H, 5.42; N, 11.89; found
(%): C, 64.63; H, 5.77; N, 11.56.
3.1.4. (Z)-4-(4-chlorophenyl)-2-(2-(1-(4-methoxyphenyl)
ethylidene)hydrazinyl)thiazole (4d)
Dirtywhite solid; mp 185–188 C; 1H NMR (400 MHz,
DMSO-d6) d 2.52(s, 3H, CH3), 3.85 (s, 3H, OCH3), 6.61 (s,
CH, thiazole), 6.99–7.01(d, 2H), 7.44–7.45 (d, 2H), 7.66–7.68
(d, 2H), 7.79–7.81 (d, 2H); 13C NMR (100 MHz, DMSO-d6)
d 16.04, 55.51, 98.92, 115.02, 119.97, 126.72, 127.21, 128.71,
130.66, 136.12, 140.85, 156.18, 161.24, 169.86; FT-IR
(KBr)1567.12, 1613.57, 3336.99; HRMS (ESI-MS) Exert M.
W: 357.0703; found: 358.0782 (M+H+); CHN analysis:
C18H16ClN3OS. Anal. Calcd. (%) for: C, 60.41; H, 4.51; N,
11.74; found (%): C, 60.76; H, 4.35; N, 11.81.
3.1.5. (Z)-4-(1-(2-(4-(4-methoxyphenyl)thiazol-2-yl)
hydrazono)ethyl)phenol (4e)
White solid; mp 174–177 C; 1H NMR (400 MHz, DMSO-d6)
d 1.90 (s, 3H, CH3), 3.83 (s, 3H, OCH3), 6.62 (s, CH, thiazole),
6.64–6.67(d, 2H), 6.78–6.80 (d, 2H), 6.88–6.90 (d, 3H), 7.27–
7.28 (d, H), 7.57–7.58 (d, H), 8.75 (s, OH); 13C NMR
(100 MHz, DMSO-d6) d 15.42, 55.39, 99.16, 114.80, 115.68,
127.09, 128.26, 159.90, 160.95, 169.26; FT-IR (KBr) 1587.25,
1615.66, 3367.45; HRMS (ESI-MS) Exert M. W: 339.1041;
found: 340.1122 (M+H+); CHN analysis: C18H17N3O2S.
Anal. Calcd. (%) for: C, 63.70; H, 5.05; N, 12.38; found
(%): C, 63.66; H, 5.36; N, 12.75.
3.1.6. (Z)-4-(4-chlorophenyl)-2-(2-(1-(4-chlorophenyl)
ethylidene)hydrazinyl)thiazole (4f)
Pale white solid; mp 197–200 C; 1H NMR (400 MHz, DMSO-
d6) d 2.52(s, 3H, CH3), 3.85 (s, 3H, OCH3), 7.36 (s, CH, thia-
zole), 7.45–7.48 (d, H), 7.52–7.53 (d, H), 7.57–7.58 (d, H), 7.72
(S, H) 7.76–7.77 (d, H); 13C NMR (100 MHz, DMSO-d6) d
14.34, 105.44, 127.71, 127.85, 127.97, 128.90, 128.98, 129.09,
129.24, 129.79, 130.53, 133.92, 170.26; FT-IR (KBr) 1587.34,
1616.79, 3439.05; HRMS (ESI-MS) Exert M. W: 361.0207;
found: 362.0287 (M+H+); CHN analysis: C17H13Cl2N3S.
Anal. Calcd. (%) for: C, 56.36; H, 3.62; N, 11.60; found
(%): C, 56.37; H, 3.57; N, 11.54.
3.1.7. (Z)-4-(4-chlorophenyl)-2-(2-(1-(3,4-dimethoxyphenyl)
ethylidene)hydrazinyl)thiazole (4g)
Dirtywhite solid; mp 195–198 C; 1HNMR (400 MHz, DMSO-
d6) d 2.27 (s, 3H, CH3), 3.79, 3.80 (s, 6H, OCH3), 6.96 (s, CH,
thiazole), 6.95–6.98 (d, H), 7.27–7.28 (d, 2H), 7.41–7.42 (d,
H), 7.44–7.45 (d, H) 7.46–7.47 (d, H), 7.86–7.87 (d, 2H), 7.87–
7.89 (d, H); 13C NMR (100 MHz, DMSO-d6) d 14.13, 55.95,
105.17, 109.19, 111.31, 119.45, 123.63, 127.71, 129.09, 130.97,
132.39, 133.97, 147.36, 148.98, 149.56, 150.25, 170.60; FT-IR
(KBr) 1586.57, 1626.69, 3431.21 ;HRMS (ESI-MS) Exert M.
W: 387.0808; found: 388.0884 (M+H+); CHN analysis C19-
H18ClN3O2S. Anal. Calcd. (%) for: C, 58.83; H, 4.68; N,
10.83; found (%): C, 58.53; H, 4.57; N, 10.73.
202 D. Chinnaraja, R. Rajalakshmi3.1.8. (Z)-4-(4-methoxyphenyl)-2-(2-(1-(thiophen-2-yl)
ethylidene) hydrazinyl) thiazole (4h)
Pale yellow solid; mp 230–233 C; 1H NMR (400 MHz,
CDCl3) d 2.60 (s, 3H, CH3), 3.86 (s, 3H, OCH3), 6.63 (s,
CH, thiazole), 7.01, 7.03 (d, 2H), 7.44–7.48 (m, 4H), 7.70,
7.82 (dd, H); 13C NMR (100 MHz, CDCl3) d 16.00, 55.47,
98.86, 115.01, 120.02, 126.70, 127.20, 128.67, 130.61, 136.15,
140.93, 156.17, 161.25, 169.90; FT-IR (KBr) 1583.56,
1616.44, 3134.25; HRMS (ESI-MS) Exert M. W: 329.0657;
found: 330.0732 (M+H+); CHN analysis: C16H15N3OS2.
Anal. Calcd. (%) for: C, 58.33; H, 4.59; N, 12.76; found
(%): C, 58.47; H, 4.51; N, 12.86.
3.1.9. (E)-2-(2-(1-(furan-2-yl)ethylidene)hydrazinyl)-4-
(4-methoxyphenyl)thiazole (4i)
Yellow solid; mp 172–175 C; 1H NMR (400 MHz, CDCl3) d
2.49 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 6.62 (s, CH, thiazole),
6.53 (s, H) 6.89, 6.90 (d, 2H), 7.56 (s, 2H) 7.65,7.67 (d, 2H);
13C NMR (100 MHz, CDCl3) d 15.13, 55.49, 98.91, 112.21,
112.92, 114.99, 120.03, 127.18, 140.84, 145.11, 147.36, 150.37,
161.21, 169.35; FT-IR (KBr) 1505.32, 1617.36, 3139.73; HRMS
(ESI-MS) Exert M. W: 313.0885; found: 314.0966 (M+H+);
CHN analysis: C16H15N3O2S. Anal. Calcd. (%) for: C, 61.32;
H, 4.82; N, 13.41; found (%): C, 61.82; H, 4.22; N, 13.75.
3.1.10. (Z)-2-(2-((4-chlorophenyl)(phenyl)methylene)
hydrazinyl)-4-(4-methoxyphenyl)thiazole(6a)
Yellow solid; mp 71–73 C; 1H NMR (400 MHz, CDCl3), d
3.82 (s, 3H, OCH3), 6.74 (s, CH, thiazole), 6.87, 6.89 (d,
2H), 7.24–7.26 (t, 3H), 7.50–7.52 (d, 2H) 7.54–7.57 (q, 4H),
7.63, 7.65(d, 2H); 13C NMR (100 MHz, CDCl3) d 55.34,
102.04, 114.00, 127.08, 127.18, 128.47, 128.61, 129.42, 130.03,
130.14, 130.25, 130.36, 136.01, 136.72, 159.38, 168.27; FT-IR
(KBr) 1607.38, 1650.78, 3376.22; HRMS (ESI-MS) Exert M.
W. 419.0859; found: 420.0933 (M+H+); CHN analysis: C23-
H18ClN3OS. Anal. Calcd. (%) for: C, 65.78; H, 4.32; N,
10.01; found (%): C, 65.66; H, 4.57; N, 9.81.
3.1.11. (Z)-4-(4-chlorophenyl)-2-(2-((4-chlorophenyl)
(phenyl)methylene)hydrazinyl)thiazole (6b)
White solid; mp 165–178 C; 1H NMR (400 MHz, CDCl3) d
6.87 (s, CH, thiazole), 7.38–7.40 (q, 7H), 7.71–7.74 (q, 6H);
13C NMR (100 MHz, CDCl3) d 104.44, 113.76, 128.61,
128.42, 127.34, 127.19, 128.11, 129.62, 131.33, 132.47, 132.25,
133.76, 136.91, 137.87, 159.38 169.87; FT-IR (KBr) 1553.95,
1605.37, 3438.63; HRMS (ESI-MS) Exert M. W: 423.0364;
found: 424.0445 (M+H+); CHN analysis: C22H15Cl2N3S.
Anal. Calcd. (%) for: C, 62.27; H, 3.56; N, 9.90; found (%):
C, 62.37; H, 3.53; N, 9.95.
3.1.12. (Z)-2-(2-((4-chlorophenyl)(phenyl)methylene)
hydrazinyl)-4-(4-nitrophenyl)thiazole (6c)
Yellow solid; mp 187–190 C; 1H NMR (400 MHz, DMSO-d6)
d 7.12 (s, CH, thiazole), 7.25 (s, H), 7.37 (s, H), 7.83–7.87 (t,
3H), 8.32, 8.34 (d, 2H), 8.39, 8.40 (d, 2H) 8.41, 8.42 (d, 2H),
8.66 (s, 2H); 13C NMR (100 MHz, DMSO-d6) d 103.54,
116.77, 121.97, 126.19, 131.23, 133.63, 135.22, 148.68, 149.63,
165.03; FT-IR (KBr)1561.64, 1616.44,1638.36, 3112.33; HRMS
(ESI-MS) Exert M. W: 434.0604; found: 435.0662 (M+H+);
CHN analysis: C22H15ClN4O2. Anal. Calcd. (%) for: C,
60.76; H, 3.48; N, 12.88; found (%): C, 60.85; H, 3.41; N, 12.76.3.1.13. (Z)-2-(2-((4-ﬂuorophenyl)(phenyl)methylene)
hydrazinyl)-4-(4-methoxyphenyl)thiazole (6d)
White solid; mp 165–167 C; 1H NMR (400 MHz, DMSO-d6)
d 3.88 (s, 3H, OCH3), 7.03 (s, CH, thiazole), 7.06, 7.07 (d, 2H),
7.08–7.09 (t, H), 7.61–7.62 (t, 2H) 7.59–7.60 (d, 2H), 7.91, 7.93
(t, H), 7.90, 7.91 (d, H), 7.86, 7.87 (d, 2H), 7.85, 7.85 (d, 2H);
13C NMR (100 MHz, DMSO-d6) d 55.97, 114.90, 129.25,
129.56, 132.34, 136.68, 150.47, 162.31, 164.81, 165.01; FT-IR
(KBr) 1610.96, 1638.36, 3002.74; HRMS (ESI-MS) Exert M.
W: 403.1155; found: 404.1234 (M+H+); CHN analysis: C23-
H18FN3OS. Anal. Calcd. (%) for: C, 68.47; H, 4.50; N,
10.41; found (%): C, 68.37; H, 4.43; N, 10.56.
3.1.14. (Z)-4-(4-chlorophenyl)-2-(2-((4-ﬂuorophenyl)
(phenyl)methylene)hydrazinyl)thiazole (6e)
Dirty white solid; mp 171–173 C; 1H NMR (400 MHz,
DMSO-d6) d 7.13 (s, CH, thiazole), 7.06, 7.07 (d, 2H), 7.08–
7.09 (t, H), 7.61–7.62 (t, H) 7.59–7.60 (d, 2H), 7.91, 7.93 (t,
H), 7.90, 7.91(d, 2H), 7.86, 7.87 (d, 2H), 7.85, 7.85 (d, 2H);
13C NMR (100 MHz, DMSO-d6) d 105.56, 113.85, 128.65,
129.33, 132.44, 135.78, 151.67, 163.61, 164.11, 166.43; FT-IR
(KBr) 1531.51, 1619.48, 3368.65; HRMS (ESI-MS) Exert M.
W: 407.0659; found: 408.0730 (M+H+); CHN analysis:
C22H15ClFN3S. Anal. Calcd. (%) for: C, 64.78; H, 3.71; N,
10.30; found (%): C, 64.78; H, 3.71; N, 10.30.
3.1.15. (Z)-4-((2-(4-(4-methoxyphenyl)thiazol-2-yl)
hydrazono)(phenyl)methyl)aniline (6f)
Pale yellow solid; mp 120–123 C; 1H NMR (400 MHz,
DMSO-d6) d 3.85 (s, 3H, OCH3), 7.12 (s, CH, thiazole), 7.25
(s, H) 7.37 (s, H), 7.83–7.87 (t, 4H), 8.32, 8.34 (d, 2H), 8.39,
8.40 (d, 2H) 8.41, 8.42 (d, 3H), 8.66 (s, 2H); 13C NMR
(100 MHz, DMSO-d6) d 56.44, 104.64, 117.63, 129.79,
131.98, 132.22, 132.73, 133.18, 133.44, 133.25, 133.95, 134.56,
136.40, 142.08, 153.99, 169.94; FT-IR (KBr) 1605.64,
1624.66, 3379.00; HRMS (ESI-MS) Exert M. W: 400.1358;
found: 401.1436 (M+H+); CHN analysis: C23H20ON4S.
Anal. Calcd. (%) for: C, 65.26; H, 4.23; N, 13.84; found
(%): C, 65.73; H, 4.33; N, 13.92.
3.1.16. (Z)-2-((2-(4-(4-methoxyphenyl)thiazol-2-yl)
hydrazono)(phenyl)methyl)-5-nitroaniline (6g)
Yellow solid; mp 130–133 C; 1H NMR (400 MHz, DMSO-d6)
d 3.64 (s, 2H, NH2), 3.91 (s, 3H, OCH3), 7.15 (s, CH, thiazole),
7.28 (s, H) 7.39–7.41 (t, 2H), 7.46–7.49 (q, 3H), 7.55–7.63 (q,
2H) 7.78–7.80 (d, 2H), 7.88–7.95 (q, 2H); 13C NMR
(100 MHz, DMSO-d6) d 56.17, 106.23, 113.95, 126.74,
127.96, 128.14, 128.27, 128.61, 131.40, 132.34, 135.72, 149.49,
152.09, 161.52, 166.76; FT-IR (KBr) 1531.51, 1614.31,
3363.47; HRMS (ESI-MS) Exert M. W: 445.1209; found:
446.1256 (M+H+); CHN analysis: C23H19N5O3S. Anal.
Calcd. (%) for: C, 62.01; H, 4.30; N, 15.72; found (%): C,
58.86; H, 3.51; N, 15.45.
3.1.17. (Z)-2-((2-(4-(4-chlorophenyl)thiazol-2-yl)
hydrazono)(phenyl)methyl)-5-nitroaniline (6h)
Dirty white solid; mp 150–153 C; 1H NMR (400 MHz,
DMSO-d6), d 3.64 (s, 2H, NH2), 7.56 (s, CH, thiazole), 7.28
(s, 2H) 7.39–7.41 (t, 2H), 7.46–7.49 (q, 2H), 7.55–7.63 (q,
2H) 7.78–7.80 (d, 2H), 7.88–7.95 (q, 2H); 13C NMR
(100 MHz, DMSO-d6) d 104.74, 115.55, 126.74, 127.96,
Synthesis of hydrazinyl thiazole derivatives 203128.14, 128.27, 128.61, 131.40, 135.72, 149.49, 152.09, 166.98;
FT-IR (KBr) 1589.04, 1616.44, 1632.88, 3134.25; HRMS
(ESI-MS) Exert M. W: 449.0713; found: 450.0166 (M+H+);
CHN analysis: C22H16ClN5O2S. Anal. Calcd. (%) for: C,




Yellow solid; mp 165–168 C; 1H NMR (400 MHz, DMSO-d6)
d 3.51 (s, 2H, NH2), 7.40 (s, CH, thiazole), 7.28 (s, H) 7.39–
7.41 (t, 2H), 7.46–7.49 (q, 2H), 7.55–7.63 (q, 2H) 7.78–7.80
(d, 2H), 7.88–7.95 (q, 3H); 13C NMR (100 MHz, DMSO-d6)
d 104.73, 116.11, 127.53, 127.93, 128.47, 128.61, 129.42,
130.03, 130.14, 131.40, 135.72, 149.49, 152.09, 166.98; FT-IR
(KBr) 1594.52, 1627.40, 3139.73; HRMS (ESI-MS) Exert M.
W: 438.0473; found: 439.0550 (M+H+);CHN analysis: C22-
H16Cl2N4S. Anal. Calcd. (%) for: C, 60.14; H, 3.67; N,
12.75; found (%): C, 60.25; H, 3.61; N, 12.86.
3.1.19. 4-(4-chlorophenyl)-2-(2-(dip-tolylmethylene)
hydrazinyl)thiazole (6j)
Pale white solid; mp 190–193 C; 1H NMR (400 MHz, DMSO-
d6) d 2.63 (s, 6H, CH3),6.74 (s, CH, thiazole), 6.87, 6.89 (d,
2H), 7.24–7.26 (t, 3H), 7.50–7.52 (d, 2H) 7.54–7.57 (q, 3H),
7.63, 7.65(d, 2H); 13C NMR (100 MHz, DMSO-d6) d 13.73,
104.44, 113.22, 126.56, 127.44, 128.69, 128.76, 129.42, 131.83,
131.91, 132.54, 136.11, 137.63, 159.58, 167.22; FT-IR (KBr)
1557.38, 1629.83, 3135.77; HRMS (ESI-MS) Exert MW:
417.1066; found: 418.1144 (M+H+); CHN analysis:
C24H20ClN3S. Anal. Calcd. (%) for: C, 68.97; H, 4.82; N,
10.05; found (%): C, 68.63; H, 4.73; N, 10.11.
3.2. General procedure for the synthesis of thiazoles (8a–d)
Equimolar quantities of 4-benzoyl pyridine thiosemicarbazone
(2.0 mmol) and substituted phenacyl bromide (2.0 mmol) 8a–d
are mixed and must be subjected to microwave irradiation for
50–120 s at a heating of 400 W. After the completion of reac-
tion it is taken out and cooled to room temperature. The solid
crude product was washed with acetonitrile (CH3CN) solvent
to get pure compounds 8a–d.
3.2.1. (Z)-4-phenyl-2-(2-(phenyl(pyridin-4-yl)methylene)
hydrazinyl)thiazole (8a)
Orange solid; mp 205–207 C; 1H NMR (400 MHz, CDCl3) d
6.98 (s, CH, thiazole), 7.06 (S, H), 7.35–7.39 (q, 4H), 7.46, 7.48
(d, 2H) 7.61–7.67 (q, 3H), 7.71, 7.73 (d, 2H) 8.78 (S, 2H); 13C
NMR (100 MHz, CDCl3) d 106.47, 125.92, 125.96, 128.40,













Scheme 1 Solvent and catalyst free syn(KBr)1605.48, 1632.52, 3443.94; HRMS (ESI-MS) Exert M.
W: 356.1096; found: 357.1176 (M+H+); CHN analysis:
C21H16N4S. Anal. Calcd. (%) for: C, 70.76; H, 4.52; N,
15.72; found (%): C, 70.41; H, 4.62; N, 15.83.
3.2.2. (Z)-4-(4-methoxyphenyl)-2-(2-(phenyl(pyridin-4-yl)
methylene)hydrazinyl)thiazole (8b)
Orange solid; mp 175–178 C; 1H NMR (400 MHz, CDCl3) d
3.82 (s, 3H, OCH3), 6.89 (s, CH, thiazole), 6.89–6.91 (d, 2H),
7.31, 7.32 (d, 2H), 7.33, 7.34 (d, 2H) 7.59 (s, H), 7.61(s, H),
7.62–7.63 (d, 2H) 7.64–7.65 (d, H) 7.66, 7.67 (d, H) 8.61 (broad
singlet, H); 13C NMR (100 MHz, CDCl3) d 55.35, 103.00,
114.09, 121.36, 127.19, 127.27, 128.61, 129.86, 130.45, 130.75,
146.66, 147.21, 151.50, 159.56, 166.95; FT-IR (KBr) 1602.53,
1633.28, 3298.63; HRMS (ESI-MS) Exert M. W: 386.1201;
found: 387.1281 (M+H+); CHN analysis: C22H18N4OS.
calcd. for. Anal. Calcd. (%) for: C, 68.37; H, 4.69; N, 14.50;
found (%): C, 68.47; H, 4.77; N, 14.61.
3.2.3. (Z)-4-(4-chlorophenyl)-2-(2-(phenyl(pyridin-4-yl)
methylene)hydrazinyl)thiazole (8c)
Orange solid; mp 207–209 C; 1H NMR (400 MHz, DMSO-d6)
d 6.90 (s, CH, thiazole), 6.99 (s, 2H), 7.35, 7.39 (d, 2H), 7.54 (s,
2H), 7.67, 7.76 (d, 3H) 8.65 (s, 2H), 8.91 (s, 2H); 13C NMR
(100 MHz, DMSO-d6) d 105.54, 117.79, 123.64, 127.17,
128.68, 128.94, 145.16, 148.22, 149.73, 1597.66, 167.53; FT-
IR (KBr) 1599.70, 1635.41, 3295.44; HRMS (ESI-MS) Exert
M. W: 390.0706; found: 391.0787 (M+H+); CHN analysis:
C21H15ClN4S. Anal. Calcd. (%) for: C, 64.53; H, 3.87; N,
14.33; found (%): C, 64.63; H, 3.71; N, 14.61.
3.2.4. (Z)-4-(4-nitrophenyl)-2-(2-(phenyl(pyridin-4-yl)
methylene)hydrazinyl)thiazole (8d)
Orange solid; mp 102–105 C; 1H NMR (400 MHz, DMSO-d6)
d 7.14 (s, CH, thiazole), 7.17, 7.18 (d, 2H), 7.44–7.48 (t, 3H),
7.58, 7.60 (d, 2H), 7.80, 7.82 (d, 2H) 7.97, 8.04 (d, 2H), 8.54
(s, H) 8.63, 8.64 (d, 2H); 13C NMR (100 MHz, DMSO-d6) d
107.68, 120.80, 122.46, 128.28, 128.62, 129.64, 130.56, 131.01,
131.37, 135.83, 142.02, 142.02, 142.79, 148.55, 167.28; FT-IR
(KBr) 1556.16, 1605.48, 3243.84; HRMS (ESI-MS) Exert M.
W: 401.0946; Found: 402.1025 (M+H+); CHN analysis:
C21H15N5O2S. Anal. Calcd. (%) for: C, 62.83; H, 3.77; N,
17.45; found (%): C, 65.72; H, 3.71; N, 17.56.
4. Results and discussion
One pot processes are very attractive and sustainable in
modern synthetic organic chemistry. A greener and more facile
procedure for the synthesis of hydrazinyl thiazoles was devel-
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Scheme 3 Solvent and catalyst free synthesis of hydrazinyl thiazoles (8a–d).
Table 1 Microwave-assisted neat synthesis of hydrazinyl thiazoles (4a–i, 6a–j).
Entry Aryl ketones, R1 (1), Ar/Ar1 (5) a-Haloketones R2 (3) Time/s Yield %
1 Acetophenone 4-Methoxy a-haloketone 40 70
2 4-NO2 acetophenone 4-Methoxy a-haloketone 45 70
3 4-OCH3 acetophenone 4-Methoxy a-haloketone 45 80
4 4-Cl acetophenone 4-Methoxy a-haloketone 30 75
5 4-OH acetophenone 4-Methoxy a-haloketone 50 60
6 4-Cl acetophenone 4-Chloro a-haloketone 30 70
7 3,4-(OCH3)2acetophenone 4-Chloro a-haloketone 30 75
8 2-Acetyl thiophenone 4-Methoxy a-haloketone 45 75
9 2-Acetyl furan 4-Methoxy a-haloketone 30 70
10 4-Cl benzophenone 4-Methoxy a-haloketone 120 75
11 4-Cl benzophenone 4-Chloro a-haloketone 30 70
12 4-Cl benzophenone 4-Nitro a-haloketone 60 75
13 4-F benzophenone 4-Methoxy a-haloketone 55 80
14 4-F benzophenone 4-a-Chlorohaloketone 155 70
15 4-Amino benzophenone 4-Methoxy a-haloketone 55 70
16 2-Amino-5-nirto benzophenone 4-Methoxy a-haloketone 175 80
17 2-Amino-5-nitro benzophenone 4-a-Chlorohaloketone 90 70
18 2-Amino,-5chloro benzophenone 4-a-Chlorohaloketone 90 80
19 4,40-Dimethylbenzophenone 4-a-Chlorohaloketone 145 80
Table 2 Microwave-assisted neat synthesis of hydrazinyl thiazoles (8a–d).
Entry 4-Benzoyl pyridinethiosemicarbazone (7) a-Haloketones R2 (3) Time/s Yield (%)
1 4-Benzoyl pyridine thiosemicarbazone a-Haloketone 50 65
2 4-Benzoyl pyridine thiosemicarbazone 4-OCH3a-haloketone 120 85
3 4-Benzoyl pyridine thiosemicarbazone 4-Cl,a-haloketone 50 75
4 4-Benzoyl pyridine thiosemicarbazone 4-NO2 a-haloketone 75 80
204 D. Chinnaraja, R. Rajalakshmithiosemicarbazones, thiosemicarbazide and a-haloketones.
The eco-friendly attributes of this process are solvent and
catalyst free conditions. The reaction protocol includes advan-
tages of short reaction time and easy work-up or puriﬁcation
step and the high purity of product.
Hence we examined the reaction of acetophenones with thi-
osemicarbazide and a-haloketones under different conditionsusing MW activation; we found that the best result was
obtained when the reaction mixture was irradiated at a power
level of 300 W for 30–175 s and 400 W for 50–120 s.
Encouraged by the result, a series of hydrazinyl thiazoles were
synthesized (Schemes 1 and 2) using substituted acetophenon-
es/benzophenones under optimized conditions and the results
are shown in Table 1. Here we found that the reaction of





























































4a 4b 4c 4d 4e






























































































Synthesis of hydrazinyl thiazole derivatives 205
206 D. Chinnaraja, R. Rajalakshmiacetophenone having the electron donating methoxy group
was rapid compared to that one having electron releasing, elec-
tron withdrawing groups and also high yield of the product
was obtained when there is the electron donating group in
the para position. However among the electron releasing
substituents, the para-hydroxy substituted acetophenone is rel-
atively less reactive and requires 50 s, 300 W of microwave
irradiation for the completion of the reaction. The yield is also
found to be very low when compared to all the synthesized
compounds (4e).
When the reaction protocol was further extended to 4-Ben-
zoyl pyridine no appreciable conversion took place Scheme 3.
Therefore even the reaction time and conditions the increasing
temperature. However the hydrazones of 4-benzoyl pyridine
react efﬁciently with a-haloketones affording the products
(Table 2).
The results of all the reactions are given in Tables 1 and 2.
The structures of all the synthesized compounds (Table 3), the
synthesized compound 4b 1H NMR (S1), 13C NMR (S2),
HSQC (S3) and HRMS (S4), were conﬁrmed, in part, by the
presence of C‚N signals around 166–170 ppm (indication of
thiazole ring) in the 13C NMR spectra. The singlet around
6.69 ppm in the 1H NMR spectrum of these compounds corre-
sponds to methine proton of the thiazole ring. To give further
evidence for the formation of the thiazole ring, HSQC spec-
trum for compound was recorded. In that spectrum the proton
signal at 6.69 ppm is well correlated with the signal at
99.5 ppm. So the signal around 6.69–7.24 ppm in all the cases,
is due to methine proton of the thiazoles ring. The HRMS
(ESI-MS) compound shows molecular ion peak at
m/z= 369.1022 (MH+). Signiﬁcant attempts were made to
synthesize hydrazinyl thiazoles by conventional method using
all the aryl ketones employed in the above mentioned green
protocol. But the products obtained were only the thiosemicar-
bazones of the corresponding ketones even after a long reac-
tion time (8a–d). However the microwave irradiation not
only yields expected thiazoles in short reaction time in many
cases but also pure products with very high yields.
5. Conclusion
In summary we have developed a novel and convenient
method for the synthesis of a series of heterocyclic compounds
possessing biologically potent thiazole nucleus with good to
excellent yield and purity.
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